The iStent inject, the latest MIGS device from Glaukos, has been approved for mild to moderate open-angle glaucoma in patients undergoing cataract surgery. Are you ready for it?
World-renowned ophthalmologist Thomas W. Samuelson, MD shares his surgical techniques and clinical results in this informative 60-minute webinar. Sightpath Medical is pleased to begin offering the iStent inject to your patients.
This webinar covers:
Surgical techniques and clinical results
Surgeon training
Reimbursement structure
How current Sightpath customers may access this technology
Complete the form at the right to view the webinar from Sightpath University.
Watch the Webinar
Enter your information below to access the Glaukos iStent inject webinar from Sightpath University.
A research team composed of scientists from the Philippines, United Kingdom, and the United States found that – compared to manual clear corneal incisions (CCI) – femtosecond laser-constructed incisions achieve better wound sealability, a quality that may reduce the risk of surgical complications.
Despite its high success rate, LASIK has been plagued with numerous myths that keep people from pursuing the surgery. What are some common myths associated with LASIK, and how should you debunk them?
